微针经皮给药系统在色素性皮肤病中的研究进展

Journal of Diagnosis and Therapy on Dermato-venereology(2022)

Cited 0|Views2
No score
Abstract
色素性皮肤病疗程长,患者长期口服药物易引起诸多不良反应,而外用药物因皮肤渗透性差治疗效果并不理想.微针经皮给药系统可穿透角质层开创多个可逆性微通道,显著提高治疗药物的渗透性,具有局部靶向性好、给药可控可持续、避免胃肠刺激和肝脏首过效应等优势.临床已尝试用于黄褐斑、白癜风和黑眼圈等色素性皮肤病的治疗.本文对微针经皮给药系统的机制及其在黄褐斑、白癜风和黑眼圈等色素性皮肤病的基础研究和临床应用作一综述,以期为临床诊疗提供更多依据.
More
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined